05:23 PM EDT, 10/28/2024 (MT Newswires) -- TransMedics Group ( TMDX ) reported Q3 net income late Monday of $0.12 per diluted share, compared with a net loss of $0.78 per share a year earlier.

Analysts polled by Capital IQ expected income of $0.31.

Revenue for the quarter that ended Sept. 30 was $108.8 million, up from $66.4 million a year earlier.

Analysts surveyed by Capital IQ expected $115 million.

For full-year 2024, the company continues to expect its revenue guidance between $425 million and $445 million. Analysts polled by Capital IQ expect $444.5 million.

Shares of TransMedics Group ( TMDX ) were down nearly 25% in after-hours activity.

Price: 94.84, Change: -31.40, Percent Change: -24.87